Unichem Labs Ghaziabad facility successfully completes USFDA inspection
The US Food and Drug Administration (USFDA) conducted an inspection of the company's Ghaziabad facility from March 3-8, 2019, and it has been successfully concluded without any USFDA form 483 issued, Unichem Labs said in a BSE filing.
New Delhi: Headquartered in Mumbai, drug firm Unichem Laboratories Monday said the US health regulator has concluded inspection of its Ghaziabad facility without making any observations.
The US Food and Drug Administration (USFDA) conducted an inspection of the company's Ghaziabad facility from March 3-8, 2019, and it has been successfully concluded without any USFDA form 483 issued, Unichem Laboratories said in a BSE filing.
Form 483 is issued by the USFDA to notify a company's management of any objectionable condition at its manufacturing facility. The form is issued after completing the inspection.
The U.S. Food and Drug Administration (FDA) is authorized to perform inspections under the Federal Food, Drug, and Cosmetic Act, Sec. 704 (21 USC §374) "Factory Inspection". Form FDA 483, "Inspectional Observations," is a form used by the FDA to document and communicate concerns discovered during these inspections.
BSEDrug firm Unichem LaboratoriesForm 483 USFDAinspectioninspection of pharmaNew DelhiShares of Unichem LaboratoriesUnichemUnichem Ghaziabad facilityUnichem LaboratoriesUnichem LabsUS Food and Drug AdministrationUS healthUSFDA
Source : PTIFarhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here
Next Story
NO DATA FOUND
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd